Search Login Register

tyrphostin A23 (AG 18) Summary

8 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Description: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source

Also Known As: AG 18; (3,4-dihydroxybenzylidene)malononitrile; (3,4-dihydroxyphenyl)methylene propanedinitrile; 3,4-dihydroxybenzylidenemalononitrile; AG-18 Show All >>

Key Diseases for which tyrphostin A23 is Relevant

  1. Shock : 1 result
  2. Prostatic Neoplasms (Prostate Cancer) : 1 result
  3. Neoplasms (Cancer) : 1 result
  4. Hypercapnia : 1 result
  5. Hepatitis B : 1 result
Show All >>

Drugs Related to tyrphostin A23

  1. Protein-Tyrosine Kinases (Tyrosine Kinase)
  2. Tyrosine (L-Tyrosine)
  3. Epidermal Growth Factor Receptor (EGF Receptor)
  4. Small Interfering RNA (siRNA)
  5. Genistein
  6. Interleukin-12 (IL 12)
  7. Verapamil (Calan)
  8. Tetanus Toxoid (Vaccine, Tetanus)
  9. Phosphotransferases (Kinase)
  10. Egtazic Acid (EGTA)
Show All >>

Therapies Related to tyrphostin A23


CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.